Jove
Visualize
Contact Us

Related Concept Videos

Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Methods to Assess Microbial Communities01:19

Methods to Assess Microbial Communities

Microbial communities, comprising bacteria, archaea, and eukaryotic microorganisms, inhabit diverse ecosystems and play crucial roles in environmental and biological processes. Their diversity is defined by three main parameters: species richness (the number of distinct species), species abundance (the relative quantity of each species), and species evenness (how uniformly individual species are distributed in various locations). These factors together shape the structure and ecological balance...
Methods to Assess Microbial Populations01:30

Methods to Assess Microbial Populations

Assessing microbial populations is crucial for understanding microbial roles in health, ecology, and industry. Various complementary techniques—both culture-based and molecular—enable detailed analysis of microbial abundance, diversity, and function.Viable Plate CountThe viable plate count is a traditional culture-based method used to estimate the number of living microbes in a sample. After serial dilution, the sample is spread onto nutrient agar plates. Each viable cell forms a visible...
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Approaches Should be Used to Prioritize Pharmaceuticals and Personal Care Products for Research on Environmental and Human Health Exposure and Effects?

Environmental toxicology and chemistry·2022
Same author

Moving Beyond the Term "Contaminants of Emerging Concern".

Environmental toxicology and chemistry·2021
Same author

Relationship of taxonomic error to frequency of observation.

PloS one·2020
Same author

Comparison of false-positive rates of 2 hypothesis-test approaches in relation to laboratory toxicity test performance.

Environmental toxicology and chemistry·2019
Same author

Simplifying environmental mixtures-An aquatic exposure-based approach via land use scenarios.

Environmental toxicology and chemistry·2018
Same author

Ecosystem services rather than designated uses should be the backbone of United States Clean Water Act programs.

Integrated environmental assessment and management·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 1, 2026

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

An approach for determining bioassessment performance and comparability.

Jerry Diamond1, James B Stribling, James R Stribling

  • 1Tetra Tech, Inc., Owings Mills, MD, USA. jerry.diamond@tetratech.com

Environmental Monitoring and Assessment
|May 26, 2011
PubMed
Summary
This summary is machine-generated.

This study assessed aquatic bioassessment data quality across U.S. states. Harmonizing ecoregional reference conditions is key for comparable macroinvertebrate bioassessment results.

More Related Videos

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

Comparison of Scale in a Photosynthetic Reactor System for Algal Remediation of Wastewater
05:40

Comparison of Scale in a Photosynthetic Reactor System for Algal Remediation of Wastewater

Published on: March 6, 2017

Related Experiment Videos

Last Updated: Jun 1, 2026

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
08:00

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays

Published on: December 4, 2016

Comparison of Scale in a Photosynthetic Reactor System for Algal Remediation of Wastewater
05:40

Comparison of Scale in a Photosynthetic Reactor System for Algal Remediation of Wastewater

Published on: March 6, 2017

Area of Science:

  • Environmental Science
  • Ecology
  • Water Quality Assessment

Background:

  • Varied sampling and analysis methods hinder aquatic bioassessment data comparability in the USA.
  • Inconsistent data quality affects large-scale ecological assessments.

Purpose of the Study:

  • To evaluate a pilot approach for assessing bioassessment performance using macroinvertebrate data.
  • To identify needs for harmonizing methods and improving data quality for aquatic ecosystems.

Main Methods:

  • Utilized macroinvertebrate data from multiple states in the Southeastern USA.
  • Evaluated bioassessment performance metrics: precision, sensitivity, and responsiveness to disturbance gradients.
  • Defined disturbance gradients using land disturbance index, specific conductance, and habitat quality.

Main Results:

  • Harmonizing ecoregional reference conditions among states is crucial for comparable bioassessment results.
  • The approach identified metrics needing refinement for improved index performance.
  • Higher performing bioassessments provide more nuanced condition assessments.

Conclusions:

  • Pilot study highlights the need for standardized reference conditions to enhance bioassessment consistency.
  • Recommends performance evaluations with at least 50 sites, including 10 reference sites.
  • Emphasizes collecting data across the full human disturbance gradient for robust statistical confidence.